CLYR Health review

The costs at a glance

Plans and purchase options

The dose tier is the most useful comparison detail

CLYR Health publishes explicit dose tiers for compounded semaglutide and tirzepatide instead of presenting one starting figure as the entire treatment budget. That is useful for a reader who already has a prescription and wants to understand the cost of a particular purchase. I would still let a clinician determine treatment rather than choose a dose from the price table. The company also offers non-GLP-1 wellness products and branded choices, but these are separate decisions. The core comparison is the exact preparation, usable supply, included care and reorder arrangement for the plan that is actually appropriate.

Semaglutide is priced as a 28-day vial

The semaglutide page describes a compounded preparation with glycine and B12, supplied in a 28-day multi-dose vial. The listed one-vial prices are $169 for 0.4 mg weekly, $199 for 0.9 mg weekly and $229 for 1.5 mg weekly. Two-vial totals are $304, $358 and $412 respectively. Those are the provider’s stated commercial tiers, not dosing recommendations from GLP1 Rank. I would compare the complete quantity and interval rather than treat a 28-day supply as a calendar month. The page says provider consultation, syringes and cold-chain shipping are included, making those items useful to check against any alternative’s quoted scope. For a closer look, read our 28-day versus monthly billing guide.

The tirzepatide starter is not the continuing price

CLYR lists a $149 tirzepatide starter month and a $269 60-day starter offer covering the first two stated treatment stages. It separately lists continuing dose options, including $249 for a one-month 5 mg weekly tier and higher prices for other tiers. I would keep the opening purchase and continuing refill on separate lines in a budget. A lower starter price may be useful, but it cannot establish the cost once the prescription changes. Ask the clinician which tier applies to you and how the preparation will be labeled; do not infer a personal treatment schedule from a product page’s commercial sequence. For a closer look, read our introductory and renewal cost guide.

One-time purchasing changes the refill responsibility

The product pages describe one-time charges and no automatic renewal. That can be attractive to readers who dislike recurring subscriptions, but it means the patient must understand when and how another clinical review or order is needed. Ask how far ahead to request a refill and what happens if a provider needs more records before prescribing again. I would not wait until the last available dose to discover the reorder process. A non-subscription arrangement reduces one kind of billing surprise, while medication continuity still depends on timely communication, clinical eligibility and pharmacy availability.

Added vitamins do not establish superior results

The compounded products are described with additional ingredients such as glycine, B12 or B6. Those formulation details should remain visible, but they do not by themselves establish a clinical advantage over another preparation. I would ask why the clinician recommends that particular formulation and which evidence supports the intended benefit. Also confirm the pharmacy, concentration, total amount and administration instructions for the actual prescription. Familiar ingredient names and attractive packaging are not enough to identify a product completely. The relevant question is whether the preparation is suitable for the individual patient and clearly explained by the prescribing and dispensing professionals. For a closer look, read our online pharmacy verification guide.

Keep the branded options in their own column

CLYR’s broader weight-loss page also presents branded options, with separate product pages and prices. Those are different transactions from compounded semaglutide with added ingredients or a tirzepatide starter vial. Compare a branded prescription with the same finished product and supply elsewhere, then add the care services included in each offer. I would not use a branded clinical outcome to predict results from every compounded preparation on the menu. A broad catalog can support a useful clinical discussion, but the prescriber needs to explain the actual choice rather than leaving the reader to treat all products as interchangeable price points.

Confirm the refund point before selecting two vials

The two-vial semaglutide discount reduces the purchase total relative to two individual vials, but it also commits the reader to more medication in one transaction. Ask when the pharmacy begins preparation, which refund conditions apply and how a clinical change affects medication not yet used. Check the labeled dates and storage instructions rather than assume every vial is usable for the full commercial term under all circumstances. I would make the larger purchase only after the clinician confirms its appropriateness and the service explains the exit conditions. A simple checkout is useful, but the financial exposure still deserves attention.

My take: strong price detail if you preserve the units

CLYR is worth examining for readers who prefer one-time orders and want published dose-specific prices. The biggest mistake would be comparing its starter amount or 28-day vial with another provider’s continuing calendar-month package without adjusting the scope. I would ask for the exact preparation and complete refill amount, then assess support and refund conditions. Strut Health provides another product-specific comparison and Found a broader continuing-care model. The better value depends on the clinical plan and how much support you need, rather than whether a company uses subscriptions or one-time transactions. Clear quantities make the comparison easier; they do not replace it. For a closer look, read our Strut Health review.

Before you sign up

• Which dose tier and 28-day quantity does my prescription require?
• Does the one-time purchase include follow-up review, and how soon should I request a reorder?
• When does preparation make a two-vial order nonrefundable?

Use the answers to compare the exact offer with another provider. A service review cannot determine whether a medication is appropriate for you; that decision belongs with your clinician.